Home/Filings/4/0001415889-25-019485
4//SEC Filing

Fiore Michael Henry 4

Accession 0001415889-25-019485

CIK 0001428336other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 4:04 PM ET

Size

8.9 KB

Accession

0001415889-25-019485

Insider Transaction Report

Form 4
Period: 2025-07-03
Fiore Michael Henry
EVP, CHIEF COMMERCIAL OFFICER
Transactions
  • Sale

    Common Stock

    2025-07-07$101.50/sh1,094$111,03853,925 total
  • Sale

    Common Stock

    2025-07-07$102.09/sh700$71,46153,225 total
  • Tax Payment

    Common Stock

    2025-07-03$100.87/sh1,636$165,02755,019 total
Footnotes (3)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.87 to $101.84 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 of this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.94 to $102.26 inclusive.

Issuer

HEALTHEQUITY, INC.

CIK 0001428336

Entity typeother

Related Parties

1
  • filerCIK 0002016116

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:04 PM ET
Size
8.9 KB